Symbols / DXR Stock $10.25 +3.12% Daxor Corporation
DXR (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.
Ratings
Current target
$10.25
Low
$22.00
High
$23.00
Mean
$22.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-03-17 | main | Ascendiant Capital | Buy → Buy | $25 |
| 2024-09-09 | main | Ascendiant Capital | Buy → Buy | $25 |
| 2019-07-29 | init | Maxim Group | — → Buy | $22 |
| 2019-05-16 | init | Ascendiant Capital | — → Buy | $20 |
News
RSS: Latest DXR news- How Daxor Corporation (DXR) Affects Rotational Strategy Timing - Stock Traders Daily Sat, 25 Apr 2026 22
- Michel, Daxor CFO, buys $9,900 in DXR stock - Investing.com ue, 31 Mar 2026 07
- 24-hour blood volume testing reaches Ohio heart failure center - Stock Titan Wed, 08 Apr 2026 07
- USAS (Americas) notches 17.7% YoY Q4 2025 revenue growth but steep EPS miss sends shares 0.76% lower. - Restructuring - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 03
- Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center - GlobeNewswire Wed, 08 Apr 2026 12
- Can Daxor (DXR) Stock Double in 2026 | Price at $9.16, Down 5.52% - Quantitative Analysis - Xã Vĩnh Công Mon, 06 Apr 2026 07
- Daxor to raise $9M in new stock sale at $11.75 a share - Stock Titan Fri, 23 Jan 2026 08
- Can Daxor (DXR) Stock Double in 2026 | Price at $9.16, Down 5.52% - Micro Trends - Xã Thanh Hà Mon, 06 Apr 2026 07
- (DXR) and the Role of Price-Sensitive Allocations - Stock Traders Daily ue, 14 Apr 2026 20
- Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 - Investing.com ue, 24 Mar 2026 07
- Southern Co. (SO) - Recent Trading Underperformance, Pre-Earnings Valuation and Rating Overview - Real Time Stock Idea Network - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 12
- DAXOR (DXR) CEO Michael Feldschuh adds 1,000 shares in open-market buy - Stock Titan Fri, 10 Apr 2026 07
- Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 - GlobeNewswire Mon, 09 Mar 2026 07
- DAXOR CORP (DXR) CFO adds 1,000 shares in open-market buy - Stock Titan ue, 31 Mar 2026 07
- Daxor CEO Feldschuh buys $9,070 in shares - Investing.com Fri, 10 Apr 2026 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
10.30
+383.53%
|
2.13
+66.41%
|
1.28
-79.71%
|
6.31
|
| Operating Revenue |
|
10.30
+383.53%
|
2.13
+66.41%
|
1.28
-79.71%
|
6.31
|
| Operating Expense |
|
1.13
-28.90%
|
1.59
+59.48%
|
1.00
-11.68%
|
1.13
|
| Selling General And Administration |
|
0.33
+11.20%
|
0.29
-4.29%
|
0.31
-71.68%
|
1.09
|
| General And Administrative Expense |
|
0.33
+11.20%
|
0.29
-4.29%
|
0.31
-71.68%
|
1.09
|
| Other Operating Expenses |
|
0.04
-25.83%
|
0.05
-9.90%
|
0.06
+30.29%
|
0.05
|
| Net Income |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Pretax Income |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Net Interest Income |
|
-0.02
+81.24%
|
-0.09
-73.29%
|
-0.05
+32.23%
|
-0.07
|
| Interest Expense |
|
0.02
-81.24%
|
0.09
+73.29%
|
0.05
-32.23%
|
0.07
|
| Interest Income |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Gain On Sale Of Security |
|
0.48
+286.68%
|
-0.26
-100.74%
|
34.43
+5984.95%
|
-0.58
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Net Income From Continuing Operation Net Minority Interest |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Net Income From Continuing And Discontinued Operation |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Net Income Continuous Operations |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Normalized Income |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Net Income Common Stockholders |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Diluted EPS |
|
1.64
+1922.22%
|
-0.09
-164.29%
|
0.14
-83.91%
|
0.87
|
| Basic EPS |
|
1.64
+1922.22%
|
-0.09
-164.29%
|
0.14
-83.91%
|
0.87
|
| Basic Average Shares |
|
4.99
+2.95%
|
4.84
+4.56%
|
4.63
+13.40%
|
4.08
|
| Diluted Average Shares |
|
4.99
+2.95%
|
4.84
+4.56%
|
4.63
+13.40%
|
4.08
|
| Diluted NI Availto Com Stockholders |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
46.01
+25.60%
|
36.63
+5.06%
|
34.87
+15.23%
|
30.26
|
| Receivables |
|
—
|
0.01
-31.84%
|
0.01
-17.61%
|
0.02
|
| Prepaid Assets |
|
—
|
—
|
—
|
0.02
|
| Investments And Advances |
|
46.00
+25.63%
|
36.61
+5.08%
|
34.84
+15.29%
|
30.22
|
| Total Liabilities Net Minority Interest |
|
0.12
-85.41%
|
0.84
-2.15%
|
0.86
-33.51%
|
1.29
|
| Payables |
|
0.12
+11.12%
|
0.11
+7.01%
|
0.10
+65.13%
|
0.06
|
| Accounts Payable |
|
0.11
|
—
|
—
|
—
|
| Total Tax Payable |
|
0.01
|
—
|
—
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
0.73
-3.40%
|
0.76
-38.52%
|
1.23
|
| Stockholders Equity |
|
45.89
+28.20%
|
35.79
+5.24%
|
34.01
+17.40%
|
28.97
|
| Common Stock Equity |
|
45.89
+28.20%
|
35.79
+5.24%
|
34.01
+17.40%
|
28.97
|
| Capital Stock |
|
0.06
+2.32%
|
0.05
+1.74%
|
0.05
+0.00%
|
0.05
|
| Common Stock |
|
0.06
+2.32%
|
0.05
+1.74%
|
0.05
+0.00%
|
0.05
|
| Share Issued |
|
5.53
+2.32%
|
5.41
+1.74%
|
5.32
+0.00%
|
5.32
|
| Ordinary Shares Number |
|
5.06
+2.54%
|
4.93
+2.66%
|
4.81
+12.01%
|
4.29
|
| Treasury Shares Number |
|
0.47
+0.00%
|
0.47
-6.90%
|
0.51
-50.25%
|
1.03
|
| Additional Paid In Capital |
|
15.53
+6.33%
|
14.61
+6.68%
|
13.69
+6.12%
|
12.90
|
| Retained Earnings |
|
34.80
+35.78%
|
25.63
+2.14%
|
25.09
+1.24%
|
24.79
|
| Treasury Stock |
|
4.50
+0.00%
|
4.50
-6.84%
|
4.83
-44.97%
|
8.77
|
| Total Equity Gross Minority Interest |
|
45.89
+28.20%
|
35.79
+5.24%
|
34.01
+17.40%
|
28.97
|
| Total Capitalization |
|
—
|
36.52
+5.05%
|
34.77
+15.12%
|
30.20
|
| Invested Capital |
|
—
|
36.52
+5.05%
|
34.77
+15.12%
|
30.20
|
| Total Debt |
|
—
|
0.73
-3.40%
|
0.76
-38.52%
|
1.23
|
| Net Debt |
|
—
|
0.73
-3.40%
|
0.76
-38.52%
|
1.23
|
| Net Tangible Assets |
|
45.89
+28.20%
|
35.79
+5.24%
|
34.01
+17.40%
|
28.97
|
| Tangible Book Value |
|
45.89
+28.20%
|
35.79
+5.24%
|
34.01
+17.40%
|
28.97
|
| Cash Cash Equivalents And Federal Funds Sold |
|
—
|
—
|
—
|
—
|
| Derivative Product Liabilities |
|
—
|
—
|
—
|
—
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
46.00
+25.63%
|
36.61
+5.08%
|
34.84
+15.29%
|
30.22
|
| Investmentin Financial Assets |
|
46.00
+25.63%
|
36.61
+5.08%
|
34.84
+15.29%
|
30.22
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
0.57
+2122.23%
|
0.03
+100.70%
|
-3.66
-375.12%
|
-0.77
|
| Net Income From Continuing Operations |
|
9.17
+1609.71%
|
0.54
+91.11%
|
0.28
-94.58%
|
5.18
|
| Other Non Cash Items |
|
1.03
-63.83%
|
2.86
-91.33%
|
33.01
+478.81%
|
-8.71
|
| Gain Loss On Investment Securities |
|
-9.65
-185.23%
|
-3.38
+90.85%
|
-37.00
-1433.20%
|
2.77
|
| Change In Working Capital |
|
0.02
+50.64%
|
0.01
-73.22%
|
0.05
+684.36%
|
-0.01
|
| Change In Receivables |
|
0.01
+114.56%
|
0.00
+48.93%
|
0.00
-77.46%
|
0.01
|
| Change In Prepaid Assets |
|
-0.01
-132.85%
|
0.02
+103.64%
|
0.01
|
—
|
| Change In Accrued Expense |
|
0.02
+303.51%
|
-0.01
-121.15%
|
0.04
+280.95%
|
-0.02
|
| Change In Payable |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Change In Other Current Liabilities |
|
0.00
|
0.00
|
0.00
+100.00%
|
-0.02
|
| Financing Cash Flow |
|
-0.57
-2122.23%
|
-0.03
-100.70%
|
3.66
+6137.53%
|
0.06
|
| Net Issuance Payments Of Debt |
|
-0.73
-2742.21%
|
-0.03
+94.57%
|
-0.47
+73.60%
|
-1.79
|
| Issuance Of Debt |
|
0.69
-65.85%
|
2.03
-50.74%
|
4.11
+0.85%
|
4.08
|
| Repayment Of Debt |
|
-1.42
+30.69%
|
-2.05
+55.27%
|
-4.59
+21.89%
|
-5.87
|
| Long Term Debt Issuance |
|
0.69
-65.85%
|
2.03
-50.74%
|
4.11
+0.85%
|
4.08
|
| Long Term Debt Payments |
|
-1.42
+30.69%
|
-2.05
+55.27%
|
-4.59
+21.89%
|
-5.87
|
| Net Long Term Debt Issuance |
|
-0.73
-2742.21%
|
-0.03
+94.57%
|
-0.47
+73.60%
|
-1.79
|
| Net Common Stock Issuance |
|
—
|
—
|
4.53
+144.60%
|
1.85
|
| Net Other Financing Charges |
|
0.16
|
0.00
|
0.00
|
0.00
|
| Changes In Cash |
|
0.00
|
0.00
|
0.00
+100.00%
|
-0.71
|
| Beginning Cash Position |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.71
|
| End Cash Position |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Free Cash Flow |
|
0.57
+2122.23%
|
0.03
+100.70%
|
-3.66
-375.12%
|
-0.77
|
| Common Stock Issuance |
|
—
|
—
|
4.53
+144.60%
|
1.85
|
| Issuance Of Capital Stock |
|
—
|
—
|
4.53
+144.60%
|
1.85
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-10 View
- 42026-03-31 View
- 42026-03-24 View
- 8-K2026-01-26 View
- 8-K2026-01-23 View
- 42025-12-11 View
- 42025-12-11 View
- 42025-11-14 View
- 8-K2025-08-07 View
- 8-K2025-07-01 View
- 42025-06-26 View
- 42025-06-26 View
- 42025-06-26 View
- 42025-06-26 View
- 42025-04-07 View
- 42025-03-27 View
- 42025-03-20 View
- 42025-03-11 View
- 42025-03-11 View
- 42024-12-10 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|